Brian Rosenberger, VP, Commercial & Business Development at Zynerba Pharmaceuticals, Inc. (ZYNE), sold 6,411 shares at $1.33 ($9K) on 2023-09-13, disclosed to the SEC on 2023-09-14.
Open-market sale of $9k ZYNE by VP, Commercial & Business Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |